Skip to content

penehyclidine for prevention of postoperative nausea and vomitting in patients undergoing gynecological laparoscopic surgery: a randomized, double-blind, controlled trial

penehyclidine for prevention of postoperative nausea and vomitting in patients undergoing gynecological laparoscopic surgery: a randomized, double-blind, controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200065258
Enrollment
Unknown
Registered
2022-11-01
Start date
2022-11-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gynecological laparoscopic surgery

Interventions

penehyclidine group:Penehycliane was used in anesthesia induction and postoperative intravenous analgesic pump
The placebo group:The same dose of normal saline was administered during anesthesia induction and postoperative intravenous analgesia pump

Sponsors

The First Affiliated Hospital of University of Science and Technology of China
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.ASA ?-?; 2. Age >=18 years; 3. BMI ? 35 kg/m^2; 4. Gynecological laparoscopic surgery.

Exclusion criteria

Exclusion criteria: 1.Preoperative use of anticholinergic drugs; 2.Patients could not understand the scoring items of various scales; 3. History of neurological and psychiatric diseases; 4. Severe heart, lung, liver and renal dysfunction; 5.Glaucoma and myasthenia gravis; 6. Previous pulmonary surgery history; 7.Preoperative chemoradiotherapy; Participated in other drug trials within 3 months.

Design outcomes

Secondary

MeasureTime frame
Severity of postoperative nausea, vomiting rate, type and dose of rescue antiemetics,Comfort (Kolcaba's Comfort Scale) and quality of recovery (QoR-15) at 24h and 48h after operation;

Primary

MeasureTime frame
The incidence of PONV;

Countries

China

Contacts

Public ContactWang Sheng

The First Affiliated Hospital of University of Science and Technology of China

iamsheng2006@163.com+86 19156007726

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026